NM_000512.5:c.120+46A>G
Variant names:
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_000512.5(GALNS):c.120+46A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: not found (cov: 20)
Exomes 𝑓: 0.000023 ( 0 hom. )
Consequence
GALNS
NM_000512.5 intron
NM_000512.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.348
Publications
0 publications found
Genes affected
GALNS (HGNC:4122): (galactosamine (N-acetyl)-6-sulfatase) This gene encodes N-acetylgalactosamine-6-sulfatase which is a lysosomal exohydrolase required for the degradation of the glycosaminoglycans, keratan sulfate, and chondroitin 6-sulfate. Sequence alterations including point, missense and nonsense mutations, as well as those that affect splicing, result in a deficiency of this enzyme. Deficiencies of this enzyme lead to Morquio A syndrome, a lysosomal storage disorder. [provided by RefSeq, Jul 2008]
TRAPPC2L (HGNC:30887): (trafficking protein particle complex subunit 2L) This gene encodes a protein that interacts with the tethering factor trafficking protein particle (TRAPP complex). TRAPP complexes mediate the contact between vescicles and target membranes, and thus, are involved in vescicle-mediated transport of proteins and lipids. The encoded protein is related to the X-linked trafficking protein particle complex 2. A related pseudogene is located on the X chromosome. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jan 2016]
TRAPPC2L Gene-Disease associations (from GenCC):
- encephalopathy, progressive, early-onset, with episodic rhabdomyolysisInheritance: AR Classification: STRONG, LIMITED Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -4 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000512.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GALNS | NM_000512.5 | MANE Select | c.120+46A>G | intron | N/A | NP_000503.1 | P34059 | ||
| GALNS | NM_001323544.2 | c.-33+46A>G | intron | N/A | NP_001310473.1 | ||||
| GALNS | NM_001323543.2 | c.-312+46A>G | intron | N/A | NP_001310472.1 | Q6YL38 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GALNS | ENST00000268695.10 | TSL:1 MANE Select | c.120+46A>G | intron | N/A | ENSP00000268695.5 | P34059 | ||
| GALNS | ENST00000568311.1 | TSL:1 | c.120+46A>G | intron | N/A | ENSP00000455006.1 | H3BNU2 | ||
| TRAPPC2L | ENST00000564365.5 | TSL:1 | c.-398+466T>C | intron | N/A | ENSP00000455447.1 | H3BPS1 |
Frequencies
GnomAD3 genomes Cov.: 20
GnomAD3 genomes
Cov.:
20
GnomAD2 exomes AF: 0.00210 AC: 94AN: 44702 AF XY: 0.00256 show subpopulations
GnomAD2 exomes
AF:
AC:
94
AN:
44702
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000233 AC: 7AN: 300664Hom.: 0 Cov.: 3 AF XY: 0.0000186 AC XY: 3AN XY: 161036 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 exome
AF:
AC:
7
AN:
300664
Hom.:
Cov.:
3
AF XY:
AC XY:
3
AN XY:
161036
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
0
AN:
8514
American (AMR)
AF:
AC:
1
AN:
14894
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
8554
East Asian (EAS)
AF:
AC:
0
AN:
15622
South Asian (SAS)
AF:
AC:
1
AN:
45984
European-Finnish (FIN)
AF:
AC:
0
AN:
15722
Middle Eastern (MID)
AF:
AC:
0
AN:
1126
European-Non Finnish (NFE)
AF:
AC:
5
AN:
173862
Other (OTH)
AF:
AC:
0
AN:
16386
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.0000000000000295319), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.289
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome Cov.: 20
GnomAD4 genome
Cov.:
20
Alfa
AF:
Hom.:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.